181 related articles for article (PubMed ID: 5309586)
1. [Behavior of the fibrin stabilizing factor (FSF) in premature infants and in some childhood diseases].
Lange MM; Lumare A; Varese L; De Sanctis C
Minerva Pediatr; 1968 Jan; 20(1):13-8. PubMed ID: 5309586
[No Abstract] [Full Text] [Related]
2. [Molecular-biology findings on various blood clotting factors].
Fiedler H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(2):121-39. PubMed ID: 4122840
[No Abstract] [Full Text] [Related]
3. Transfusion support for congenital clotting deficiencies other than haemophilia.
Lewis JH; Spero JA; Ragni MV; Bontempo FA
Clin Haematol; 1984 Feb; 13(1):119-35. PubMed ID: 6609789
[No Abstract] [Full Text] [Related]
4. [Blood coagulation disorders caused by abnormal blood coagulation factors].
Fiedler H
Z Arztl Fortbild (Jena); 1972 Jul; 66(13):692-8. PubMed ID: 4636972
[No Abstract] [Full Text] [Related]
5. Prothrombin utilization in congenital coagulation deficiency states.
Owen CA; Thompson JH
Thromb Diath Haemorrh; 1971 Jun; 25(2):297-311. PubMed ID: 5568049
[No Abstract] [Full Text] [Related]
6. [Proceedings: Blood coagulation disorders in the pediatric age. Introduction].
Grasso E
Minerva Pediatr; 1973 Nov; 25(41):1829-32. PubMed ID: 4774584
[No Abstract] [Full Text] [Related]
7. [Activity of the fibrin stabilizing factor in several diseases in children].
Alekseenko IF
Vopr Okhr Materin Det; 1970 Feb; 15(2):90. PubMed ID: 5462401
[No Abstract] [Full Text] [Related]
8. [On the coagulation factors from V through XIII].
Yoshida K; Tagawa N
Nihon Rinsho; 1973 Apr; 31(4):755-64. PubMed ID: 4580392
[No Abstract] [Full Text] [Related]
9. [Experimental models of human congenital coagulation defects].
Kase F
Probl Gematol Pereliv Krovi; 1981 Nov; 26(11):41-4. PubMed ID: 7033960
[No Abstract] [Full Text] [Related]
10. Hereditary and acquired hemorrhagic disorders in animals.
Dodds WJ
Prog Hemost Thromb; 1974; 2(0):215-47. PubMed ID: 4604529
[No Abstract] [Full Text] [Related]
11. [Proceedings: Genetic aspects of hereditary coagulopathies].
Rasore-Quartino A
Minerva Pediatr; 1973 Nov; 25(41):1846-67. PubMed ID: 4544077
[No Abstract] [Full Text] [Related]
12. Genetic aspects of hemostasis. A review.
Quick AJ
Thromb Diath Haemorrh; 1968 Nov; 20(1):209-26. PubMed ID: 4884913
[No Abstract] [Full Text] [Related]
13. [Screening and therapy of coagulation factor deficiency in new born infants].
Cagini P; Trabalza N; Cappuccini B; Perocchi F; Barboni G; Carnevali A
Minerva Pediatr; 1979 Nov; 31(22):1581-6. PubMed ID: 555506
[No Abstract] [Full Text] [Related]
14. Inhibitor of human blood coagulation elicited by thrombin.
Marciniak E
J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460
[No Abstract] [Full Text] [Related]
15. [Diseases analogous to hemophilia].
Matsuoka M; Mizushina T
Saishin Igaku; 1969 Apr; 24(4):860-8. PubMed ID: 4897036
[No Abstract] [Full Text] [Related]
16. Stainable blood platelet glycogen in various conditions.
Hermanský F; Hrodek O; Matousová O; Cieslar P
Acta Univ Carol Med Monogr; 1972; 53():165-71. PubMed ID: 4598518
[No Abstract] [Full Text] [Related]
17. Some effects of a microcrystalline collagen preparation on blood.
Mason RG; Read MS
Haemostasis; 1974; 3(1):31-45. PubMed ID: 4215704
[No Abstract] [Full Text] [Related]
18. [Modern trends in the therapy of congenital and acquired coagulopathies].
Girolami A
Clin Ter; 1968 Jun; 45(5):469-93. PubMed ID: 4901167
[No Abstract] [Full Text] [Related]
19. Reduction of fibrin stabilizing factor (FSF) in thrombocytopenia in childhood.
Ströder J
Ann Paediatr; 1965; 205(6):438-41. PubMed ID: 5898747
[No Abstract] [Full Text] [Related]
20. [Ontogenetic variability of fibrin stabilizing factor level (FSF--Factor XIII of blood coagulation system) in the plasma of healthy children].
Zuch A; Rudobielska M; Zwierzowa W; Jurgielewicz E; Buluk K
Pediatr Pol; 1972 Oct; 47(10):1197-203. PubMed ID: 5085405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
